Rosuvastatin safety: lessons from the FDA review and post-approval surveillance

Author: Davidson Michael H  

Publisher: Informa Healthcare

ISSN: 1474-0338

Source: Expert Opinion on Drug Safety, Vol.3, Iss.6, 2004-11, pp. : 547-557

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract